New FDA Guidance on Off-Label Promotion Falls Short for Everyone: Obama Administration Is Likely to Revisit It

Lignende værker

• President Obama Reopens Debate On Patented Biologics: Will the FDA Quickly Define an Abbreviated Pathway for Biosimilars?
  af: Barlas, Stephen
  Udgivet: (2011)
• New Challenges to the FDA’s Drug-Labeling Policy: Democrats Are Poised to Pounce
  af: Barlas, Stephen
  Udgivet: (2008)
• Off-Label Drug Promotion Now on the Table: House and Senate Voice Concerns
  af: Barlas, Stephen
  Udgivet: (2008)
• The FDA’s New Guidance for Off-Label Promotion Is Only a Start
  af: Field, Robert I.
  Udgivet: (2008)
• FDA Science Base Badly Eroded: But Will Congress Provide Urgent New Funding?
  af: Barlas, Stephen
  Udgivet: (2008)